Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

New York City launches $100 million universal health insurance program

New York City launched a $100 million health insurance program to cover 600,000 uninsured residents, including those unable to afford coverage and those living in the United States illegally.

Read More »

Stocks fall as judge rules Obamacare unconstitutional

Shares of U.S. health insurers, hospitals, and healthcare companies fell after a federal judge ruled that Barack Obama’s signature healthcare law was unconstitutional.

Read More »

Republican pricing projects could hit industry bottom line

Prices, profits and promotional spend are closely linked. Reduce prices and promotion will plummet. But wait, the Republicans are in control. Accordingly, pharma, its marketing partners and even Wall Street often rest easy, especially when Republicans control Congress and the White House.

Read More »

Sales and Marketing: Facts & Figures

Health care continues to be one of the top issues that voters want to hear candidates talk about during their 2018 congressional campaigns, according to the results of Kaiser Health’s June 2018 tracking poll.

Read More »

Democrats refocus fight against Trump’s Supreme Court nominee on healthcare

Democrats reoriented their uphill push to block U.S. Senate confirmation of President Donald Trump’s nominee to the Supreme Court, moving healthcare to the center of their strategy and putting less emphasis on abortion rights.

Read More »

Has Trump been good for medical marketing?

While many of us from blue states and urban bubbles fret over some of the actions of President Donald Trump, it’s good to take a clear-eyed view of whether or not Trump and this administration has been good for the medical marketing industries. Moreover, it’s useful to consider how a “blue wave” in the midterm elections might change the dynamic.

Read More »

Opioid makers paid millions to advocacy groups: U.S. Senate report

Five opioid manufacturers including OxyContin maker Purdue Pharma LP paid more than $10 million to advocacy groups and doctors tied to them, many of whom amplified industry messages supporting the use of the painkillers, a U.S. Senate report.

Read More »

U.S. Senate committee advances Azar nomination as health secretary

A U.S. Senate committee voted to move forward the nomination of Alex Azar, a former drug industry executive and lobbyist whom President Donald Trump has tapped to be the next secretary of Health and Human Services.

Read More »

Republicans propose to delay, pause Obamacare taxes

U.S. House Republicans proposed to delay or suspend several taxes under former President Barack Obama’s healthcare law, including a tax on medical devices and the so-called “Cadillac” tax on generous health insurance plans.

Read More »

U.S. Senate tax bill accomplishes major Obamacare repeal goal

The sweeping tax overhaul that passed the U.S. Senate contains the Republicans’ biggest blow yet to former President Barack Obama’s healthcare law, repealing the requirement that all Americans obtain health insurance.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom